acasă
>
produs
>
Reactivi de imunofluorescență
>
Boală infecțioasă
>
Kit de testare rapidă combinată antigen SARS-CoV-2 / Grip A+B

Kit de testare rapidă combinată antigen SARS-CoV-2 / Grip A+B

Easy Storage: 4-30℃

INTENDED USE

The SARS-CoV-2 / Influenza A+B Antigen Combo Rapid Test Kit (Fluorescence immunochromatography) is intended for vitro qualitative detection of SARS-CoV-2 and Influenza A/B virus antigens in human nasopharyngeal swab (NPS) and Oropharyngeal swab(OPS).

For professional in vitro diagnostic use only.

CLINICAL SIGNIFICANCE

The SARS-CoV-2 belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the SARS-CoV-2 are the main source of infection; Asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases. SARS-CoV-2 antigens can usually be detected in upper respiratory tract samples during the acute phase of infection. A positive result indicates the presence of viral antigens, but the clinical and medical history and other diagnostic information must be combined to determine the infection status.

Influenza, often referred to as flu, is caused by the influenza virus, a highly contagious viral infection of the respiratory tract that can be spread by coughing or sneezing. Influenza outbreaks occur every fall and winter. Influenza is divided into influenza A virus, influenza B virus and influenza C virus. Influenza A virus has strong variability, followed by influenza B virus, and influenza C virus is relatively stable.

Fever, sore throat, myalgia, dry cough, and fatigue are common symptoms in patients with new coronary pneumonia SARS-CoV-2. Influenza A/B may also show patchy and ground-glass opacities in the lungs. Under the prevention and control of the new crown epidemic, it is of great significance to quickly identify the new crown and influenza A and B, which can avoid misdiagnosis and missed diagnosis, reduce the pressure on medical staff, and improve medical efficiency. The SARS-CoV-2 / Influenza A+B Antigen Combo Rapid Test Kit (Fluorescence immunochromatography) uses nasopharyngeal or oropharyngeal swab specimens to provide a simple and quick auxiliary differential diagnosis method for new coronary pneumonia SARS-CoV-2 and influenza A/B.